FOXC1 and neoplasm: XIST exerts its oncogenic function by decreasing blood-tumour barrier permeability and promoting angiogenesis through the XIST-miR-137-Rac1 pathway [21] or the XIST-miR-137-FOXC1/ZO-2 pathway [22].